Copyright Reports & Markets. All rights reserved.

Global Percutaneous Left Atrial Appendage Closure Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Percutaneous Left Atrial Appendage Closure Device Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Endocardial LAA Closure Devices
    • 1.3.3 Epicardial LAA Closure Devices
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Percutaneous Left Atrial Appendage Closure Device Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals
    • 1.4.3 Ambulatory Surgery Centres
    • 1.4.4 Others
  • 1.5 Global Percutaneous Left Atrial Appendage Closure Device Market Size & Forecast
    • 1.5.1 Global Percutaneous Left Atrial Appendage Closure Device Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Percutaneous Left Atrial Appendage Closure Device Sales Quantity (2020-2031)
    • 1.5.3 Global Percutaneous Left Atrial Appendage Closure Device Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.1.4 Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Abbott Laboratories Recent Developments/Updates
  • 2.2 AtriCure
    • 2.2.1 AtriCure Details
    • 2.2.2 AtriCure Major Business
    • 2.2.3 AtriCure Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.2.4 AtriCure Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 AtriCure Recent Developments/Updates
  • 2.3 Boston Scientific Corporation
    • 2.3.1 Boston Scientific Corporation Details
    • 2.3.2 Boston Scientific Corporation Major Business
    • 2.3.3 Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.3.4 Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Boston Scientific Corporation Recent Developments/Updates
  • 2.4 Johnson and Johnson
    • 2.4.1 Johnson and Johnson Details
    • 2.4.2 Johnson and Johnson Major Business
    • 2.4.3 Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.4.4 Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Johnson and Johnson Recent Developments/Updates
  • 2.5 Lifetech Scientific Corporation
    • 2.5.1 Lifetech Scientific Corporation Details
    • 2.5.2 Lifetech Scientific Corporation Major Business
    • 2.5.3 Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.5.4 Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Lifetech Scientific Corporation Recent Developments/Updates
  • 2.6 Occlutech GmbH
    • 2.6.1 Occlutech GmbH Details
    • 2.6.2 Occlutech GmbH Major Business
    • 2.6.3 Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.6.4 Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Occlutech GmbH Recent Developments/Updates
  • 2.7 Biosense Webster Inc
    • 2.7.1 Biosense Webster Inc Details
    • 2.7.2 Biosense Webster Inc Major Business
    • 2.7.3 Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.7.4 Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Biosense Webster Inc Recent Developments/Updates
  • 2.8 SentreHeart Inc.
    • 2.8.1 SentreHeart Inc. Details
    • 2.8.2 SentreHeart Inc. Major Business
    • 2.8.3 SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.8.4 SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 SentreHeart Inc. Recent Developments/Updates
  • 2.9 MEDX Xelerator LP
    • 2.9.1 MEDX Xelerator LP Details
    • 2.9.2 MEDX Xelerator LP Major Business
    • 2.9.3 MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.9.4 MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 MEDX Xelerator LP Recent Developments/Updates
  • 2.10 Cardia Inc
    • 2.10.1 Cardia Inc Details
    • 2.10.2 Cardia Inc Major Business
    • 2.10.3 Cardia Inc Percutaneous Left Atrial Appendage Closure Device Product and Services
    • 2.10.4 Cardia Inc Percutaneous Left Atrial Appendage Closure Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Cardia Inc Recent Developments/Updates

3 Competitive Environment: Percutaneous Left Atrial Appendage Closure Device by Manufacturer

  • 3.1 Global Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue by Manufacturer (2020-2025)
  • 3.3 Global Percutaneous Left Atrial Appendage Closure Device Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Percutaneous Left Atrial Appendage Closure Device by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Percutaneous Left Atrial Appendage Closure Device Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Percutaneous Left Atrial Appendage Closure Device Manufacturer Market Share in 2024
  • 3.5 Percutaneous Left Atrial Appendage Closure Device Market: Overall Company Footprint Analysis
    • 3.5.1 Percutaneous Left Atrial Appendage Closure Device Market: Region Footprint
    • 3.5.2 Percutaneous Left Atrial Appendage Closure Device Market: Company Product Type Footprint
    • 3.5.3 Percutaneous Left Atrial Appendage Closure Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Percutaneous Left Atrial Appendage Closure Device Market Size by Region
    • 4.1.1 Global Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Percutaneous Left Atrial Appendage Closure Device Consumption Value by Region (2020-2031)
    • 4.1.3 Global Percutaneous Left Atrial Appendage Closure Device Average Price by Region (2020-2031)
  • 4.2 North America Percutaneous Left Atrial Appendage Closure Device Consumption Value (2020-2031)
  • 4.3 Europe Percutaneous Left Atrial Appendage Closure Device Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Percutaneous Left Atrial Appendage Closure Device Consumption Value (2020-2031)
  • 4.5 South America Percutaneous Left Atrial Appendage Closure Device Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Type (2020-2031)
  • 5.2 Global Percutaneous Left Atrial Appendage Closure Device Consumption Value by Type (2020-2031)
  • 5.3 Global Percutaneous Left Atrial Appendage Closure Device Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Application (2020-2031)
  • 6.2 Global Percutaneous Left Atrial Appendage Closure Device Consumption Value by Application (2020-2031)
  • 6.3 Global Percutaneous Left Atrial Appendage Closure Device Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Type (2020-2031)
  • 7.2 North America Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Application (2020-2031)
  • 7.3 North America Percutaneous Left Atrial Appendage Closure Device Market Size by Country
    • 7.3.1 North America Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Percutaneous Left Atrial Appendage Closure Device Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Type (2020-2031)
  • 8.2 Europe Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Application (2020-2031)
  • 8.3 Europe Percutaneous Left Atrial Appendage Closure Device Market Size by Country
    • 8.3.1 Europe Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Percutaneous Left Atrial Appendage Closure Device Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Percutaneous Left Atrial Appendage Closure Device Market Size by Region
    • 9.3.1 Asia-Pacific Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Percutaneous Left Atrial Appendage Closure Device Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Type (2020-2031)
  • 10.2 South America Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Application (2020-2031)
  • 10.3 South America Percutaneous Left Atrial Appendage Closure Device Market Size by Country
    • 10.3.1 South America Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Percutaneous Left Atrial Appendage Closure Device Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Market Size by Country
    • 11.3.1 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Percutaneous Left Atrial Appendage Closure Device Market Drivers
  • 12.2 Percutaneous Left Atrial Appendage Closure Device Market Restraints
  • 12.3 Percutaneous Left Atrial Appendage Closure Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Percutaneous Left Atrial Appendage Closure Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Percutaneous Left Atrial Appendage Closure Device
  • 13.3 Percutaneous Left Atrial Appendage Closure Device Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Percutaneous Left Atrial Appendage Closure Device Typical Distributors
  • 14.3 Percutaneous Left Atrial Appendage Closure Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Percutaneous Left Atrial Appendage Closure Device market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Percutaneous Left Atrial Appendage Closure Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Percutaneous Left Atrial Appendage Closure Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Percutaneous Left Atrial Appendage Closure Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Percutaneous Left Atrial Appendage Closure Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Percutaneous Left Atrial Appendage Closure Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Percutaneous Left Atrial Appendage Closure Device
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Percutaneous Left Atrial Appendage Closure Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, AtriCure, Boston Scientific Corporation, Johnson and Johnson, Lifetech Scientific Corporation, Occlutech GmbH, Biosense Webster Inc, SentreHeart Inc., MEDX Xelerator LP, Cardia Inc, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Percutaneous Left Atrial Appendage Closure Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Endocardial LAA Closure Devices
    Epicardial LAA Closure Devices
    Market segment by Application
    Hospitals
    Ambulatory Surgery Centres
    Others
    Major players covered
    Abbott Laboratories
    AtriCure
    Boston Scientific Corporation
    Johnson and Johnson
    Lifetech Scientific Corporation
    Occlutech GmbH
    Biosense Webster Inc
    SentreHeart Inc.
    MEDX Xelerator LP
    Cardia Inc
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Percutaneous Left Atrial Appendage Closure Device product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Percutaneous Left Atrial Appendage Closure Device, with price, sales quantity, revenue, and global market share of Percutaneous Left Atrial Appendage Closure Device from 2020 to 2025.
    Chapter 3, the Percutaneous Left Atrial Appendage Closure Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Percutaneous Left Atrial Appendage Closure Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Percutaneous Left Atrial Appendage Closure Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Percutaneous Left Atrial Appendage Closure Device.
    Chapter 14 and 15, to describe Percutaneous Left Atrial Appendage Closure Device sales channel, distributors, customers, research findings and conclusion.

    Buy now